Jerry S. Lanchbury, Chief Scientific Officer at MYRIAD GENETICS INC (MYGN), sold 38,720 shares at $31.97 ($1.2M) on 2021-05-04, disclosed to the SEC on 2021-05-05.
Open-market sale of $1.2M MYGN by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $31.97 | 19,360 | $619K | 50.0% |
| 2 | $31.97 | 19,360 | $619K | 50.0% |
| Total | $31.97 avg | 38,720 | $1.2M | 100% |
| Filing → |
| MYGN | SELL | 2021-08-06 | $2.0M | — | Filing → |
| MYGN | SELL | 2021-08-05 | $4.5M | — | Filing → |
| MYGN | SELL | 2021-07-14 | $4.9M | — | Filing → |